|
SHAREHOLDERS' EQUITY (Details) (USD $)
|
0 Months Ended | 9 Months Ended |
|---|---|---|
|
May 10, 2010
|
Sep. 30, 2014
|
|
| Shareholders Equity [Line Items] | ||
| Fair values of financial instruments | $ 11,288,070 | |
| Gross proceeds | 10,805,750 | 10,805,750 |
| Direct financing costs | (1,742,993) | |
| Fair value of placement agent warrants | 187,366 | |
| Financing Cost Fair Value | 9,250,123 | |
|
Series A Preferred Stock [Member]
|
||
| Shareholders Equity [Line Items] | ||
| Fair values of financial instruments | 10,248,092 | |
| Gross proceeds | 9,810,227 | |
| Direct financing costs | (1,581,550) | |
| Fair value of placement agent warrants | 0 | |
| Financing Cost Fair Value | 8,228,677 | |
|
Warrant [Member]
|
||
| Shareholders Equity [Line Items] | ||
| Fair values of financial instruments | 1,039,978 | |
| Gross proceeds | 995,523 | |
| Direct financing costs | (161,443) | |
| Fair value of placement agent warrants | 187,366 | |
| Financing Cost Fair Value | $ 1,021,446 |